In D-LIFT, dulaglutide significantly reduced GGT compared with control (between-group difference −13.1 U/L, p = 0.025), but changes in AST and ALT did not reach statistical significance [ 15 ].
← all excerpts
Therapeutic Effects of Glucagon-like Peptide-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: A Systematic Review.
1
—
—